AzTrials
AzTrials

Adhesive CapsulitisRCTNCT07323225

Neural Mobilization and Capsular Stretching in Adhesive Capsulitis

A study testing capsular stretching plus neural mobilization, anterior, inferior and posterior capsular stretching and traditional exercises in people with Adhesive Capsulitis, run by Prince Sattam Bin Abdulaziz University at 1 site in Saudi Arabia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Restriction of glenohumeral (GH) mobility in patients with adhesive capsulitis (AC) was known owing to capsular adhesion. There is a little evidence about the involvement of neural restriction in limiting range of motion (ROM) of the GH joint in patients with AC. Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
Adhesive Capsulitis
What is being tested?
capsular stretching plus neural mobilization, anterior, inferior and posterior capsular stretching and traditional exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSaudi Arabia
Study dates
1 Jan 2026to 10 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients from both gender (male \&female) will be included if they would have second or third stage AC with their age between forty and seventy years
  • experiencing pain, capsular adhesions, and a reduction of greater than fifty percentage in passive ROM of the GH joint (external rotation, abduction, and internal rotation compared to the sound side
  • lasting for a minimum of three months. Patients with positive upper limb tension test-1 will be also included in this study

Who cannot join

  • they would have stroke,Parkinson's diseases that interfere with shoulder muscles activity
  • diabetes
  • traumatic shoulder conditions
  • glenohumeral osteoarthritis confirmed by x-ray
  • previous surgery, and manipulation of the affected GH joint under general anesthesia
  • Patients with passive elbow extension ROM

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Saudi Arabia1 site
  • Prince Sattam bin Abdulaziz University

    Al Kharj, 16242

    Mohammed, Phd, 00966115886387 ext. 00966115886387, m.hegazy@psau.edu.sa

Other trials in Saudi Arabia

About this study

Official title: Effectiveness of Combined Neural Mobilization Techniques and Capsular Stretching Exercises in Patients With Adhesive Capsulitis.

Restriction of glenohumeral (GH) mobility in patients with adhesive capsulitis (AC) was known owing to capsular adhesion. There is a little evidence about the involvement of neural restriction in limiting range of motion (ROM) of the GH joint in patients with AC. Objectives: The purpose of this study is to investigate the combined effect of median nerve mobilization and capsular stretching on improving shoulder external rotation, abduction and internal rotation ROM among patients with AC. Methods Thirty patients will be randomly assigned into two equal groups : Group (A) will receive median nerve mobilization and capsular stretching while Group (B) will receive only capsular stretching (anterior, posterior and anteroinferior capsular stretching). Both groups will receive passive and self-assisted exercises. All patients in both groups will be evaluated pre and post treatment for GH external rotation, abduction and internal rotation ROM.

Being tested
capsular stretching plus neural mobilization, anterior, inferior and posterior capsular stretching, traditional exercises
Keywords
Adhesive capsulitis, neural mobilization, capsular stretch
Medical subject headings
Bursitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • capsular stretching plus neural mobilizationOther

    anterior, posterior and inferior capsular stretching and neural mobilization

  • anterior, inferior and posterior capsular stretchingOther

    anterior, inferior and posterior glenohumeral capsular stretching

  • traditional exercisesOther

    stretching exercises for anterior GH musculture plus auto passive exercises and pendulum exercises

Study groups in NCT07323225
Study groupRoleWhat they receive
Neural mobilization groupExperimentalneural mobilization plus capsular stretching
Receives: Other: capsular stretching plus neural mobilization
Capsular stretching groupActive comparatorcapsular stretching
Receives: Other: anterior, inferior and posterior capsular stretching
Control groupActive comparatortraditional execises
Receives: Other: traditional exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain intensity

    pain was assessed by VAS which has two ends. the left end indicates no pain where the right end indicates maximal pain

    Measured: 4 Weeks

  2. central sensitization

    central sensitization will be assessed by the the arabic version of central sensitizatuion questionnaire. To understand CSI scores, the following severity categories have been established: subclinical = 0 to 29; mild = 30 to 39; moderate = 40 to 49; severe = 50 to 59; and extreme = 60 to 100

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2026
  2. Study start1 Jan 2026 (estimated)
  3. Primary completion1 Apr 2026 (estimated)
  4. Study completion10 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
three groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07323225
Sponsor's protocol ID
RHPT/024/009
Acronym
RCT
Status last verified
Dec 2025
First submitted
15 Dec 2025
Last updated
7 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Coppieters MW, Butler DS. Do 'sliders' slide and 'tensioners' tension? An analysis of neurodynamic techniques and considerations regarding their application. Man Ther. 2008 Jun;13(3):213-21. doi: 10.1016/j.math.2006.12.008. Epub 2007 Mar 30.

    PubMed 17398140
  • Martinez-Merinero P, Lluch E, Gallezo-Izquierdo T, Pecos-Martin D, Plaza-Manzano G, Nunez-Nagy S, Falla D. The influence of a depressed scapular alignment on upper limb neural tissue mechanosensitivity and local pressure pain sensitivity. Musculoskelet Sci Pract. 2017 Jun;29:60-65. doi: 10.1016/j.msksp.2017.03.001. Epub 2017 Mar 10.

    PubMed 28319883

Questions about this trial

What is this clinical trial studying?

A study testing capsular stretching plus neural mobilization, anterior, inferior and posterior capsular stretching and traditional exercises in people with Adhesive Capsulitis, run by Prince Sattam Bin Abdulaziz University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 7 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mohammed Hegazy (00966566169893 ext. 00966115886387, mohamed.mostafa@pt.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain intensity (time frame: 4 Weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07323225, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in